Skip to main content

and
  1. No Access

    Article

    Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial

    PTCL patients exhibit poor survival with existing treatments. We investigated the efficacy of CHOP combined with alemtuzumab in 116 PTCL patients age 61–80 in an open-label, randomized phase 3 trial. Alemtuzum...

    Gerald G. Wulf, Bettina Altmann, Marita Ziepert, Francesco D’Amore in Leukemia (2021)

  2. No Access

    Article

    Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease

    Salvage chemotherapy induces disease remissions in patients with relapsed or refractory (r/r) T-cell lymphomas, but fails to provide lasting tumor control. We analyzed the outcome after peripheral blood stem a...

    Gerald Wulf, Justin Hasenkamp, Wolfram Jung in Bone Marrow Transplantation (2019)

  3. Article

    Open Access

    X-linked Charcot-Marie-Tooth disease, Arts syndrome, and prelingual non-syndromic deafness form a disease continuum: evidence from a family with a novel PRPS1 mutation

    X-linked Charcot-Marie-Tooth disease type 5 (CMTX5), Arts syndrome, and non-syndromic sensorineural deafness (DFN2) are allelic syndromes, caused by reduced activity of phosphoribosylpyrophosphate synthetase 1...

    Matthis Synofzik, Jennifer Müller vom Hagen in Orphanet Journal of Rare Diseases (2014)